Kezar Life Sciences
KZR
KZR
127 hedge funds and large institutions have $442M invested in Kezar Life Sciences in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 51 increasing their positions, 34 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
+4
Holders Change %
+3.25%
% of All Funds
2.15%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
30
Increased
51
Reduced
34
Closed
24
Calls
$33.7M
Puts
$6.72M
Net Calls
+$27M
Net Calls Change
+$17.4M
Top Buyers
| 1 |
SCM
1
Suvretta Capital Management
New York
|
$36.5M |
| 2 |
2
Millennium Management
New York
|
$22.7M |
| 3 |
CA
3
CHI Advisors
New York
|
$15.2M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$15.8M |
| 5 |
DM
5
Deerfield Management
New York
|
$11.7M |
